Archives

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
Madrigal Pharmaceuticals to Release Fourth-Quarter and Full-Year 2024 Financial Results and Host Webcast on February 26, 2025
Market Updates

Madrigal Pharmaceuticals to Release Fourth-Quarter and Full-Year 2024 Financial Results and Host Webcast on February 26, 2025

CONSHOHOCKEN, Pa., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) announced today that it will release its fourth-quarter and full-year 2024 financial results on Wedne...

  • February 12, 2025 05:00 AM PST
  • EODHD
KALA BIO Announces Chief Executive Officer Transition
Market Updates

KALA BIO Announces Chief Executive Officer Transition

ARLINGTON, Mass., Feb. 12, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative...

  • February 12, 2025 05:00 AM PST
  • EODHD
NCR Atleos Announces Date of Fourth Quarter and Full Year 2024 Earnings Conference Call
Market Updates

NCR Atleos Announces Date of Fourth Quarter and Full Year 2024 Earnings Conference Call

ATLANTA, February 12, 2025--(BUSINESS WIRE)--NCR Atleos Corporation (NYSE: NATL) ("Atleos") will release fourth quarter and full year 2024 financial results after the market close on Monday, March 3,...

  • February 12, 2025 05:00 AM PST
  • EODHD